Logo image of DNUT

KRISPY KREME INC (DNUT) Stock Fundamental Analysis

NASDAQ:DNUT - Nasdaq - US50101L1061 - Common Stock - Currency: USD

2.89  -0.04 (-1.37%)

After market: 2.91 +0.02 (+0.69%)

Fundamental Rating

2

DNUT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. DNUT has a bad profitability rating. Also its financial health evaluation is rather negative. DNUT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

DNUT had negative earnings in the past year.
In the past year DNUT had a positive cash flow from operations.
In the past 5 years DNUT reported 4 times negative net income.
In the past 5 years DNUT always reported a positive cash flow from operatings.
DNUT Yearly Net Income VS EBIT VS OCF VS FCFDNUT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

With a Return On Assets value of -0.70%, DNUT is not doing good in the industry: 66.42% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -1.97%, DNUT is in line with its industry, outperforming 50.75% of the companies in the same industry.
Industry RankSector Rank
ROA -0.7%
ROE -1.97%
ROIC N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
DNUT Yearly ROA, ROE, ROICDNUT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -2 -4 -6 -8

1.3 Margins

DNUT's Gross Margin of 30.78% is on the low side compared to the rest of the industry. DNUT is outperformed by 76.87% of its industry peers.
In the last couple of years the Gross Margin of DNUT has remained more or less at the same level.
DNUT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.78%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
DNUT Yearly Profit, Operating, Gross MarginsDNUT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

DNUT does not have a ROIC to compare to the WACC, probably because it is not profitable.
DNUT has more shares outstanding than it did 1 year ago.
DNUT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DNUT is higher compared to a year ago.
DNUT Yearly Shares OutstandingDNUT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
DNUT Yearly Total Debt VS Total AssetsDNUT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

DNUT has an Altman-Z score of 0.35. This is a bad value and indicates that DNUT is not financially healthy and even has some risk of bankruptcy.
DNUT has a worse Altman-Z score (0.35) than 80.60% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that DNUT is somewhat dependend on debt financing.
DNUT has a Debt to Equity ratio of 0.85. This is in the better half of the industry: DNUT outperforms 65.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACCN/A
WACC8.23%
DNUT Yearly LT Debt VS Equity VS FCFDNUT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

DNUT has a Current Ratio of 0.35. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
DNUT has a Current ratio of 0.35. This is amonst the worse of the industry: DNUT underperforms 84.33% of its industry peers.
DNUT has a Quick Ratio of 0.35. This is a bad value and indicates that DNUT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DNUT (0.28) is worse than 84.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.28
DNUT Yearly Current Assets VS Current LiabilitesDNUT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

2

3. Growth

3.1 Past

DNUT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.00%.
DNUT shows a decrease in Revenue. In the last year, the revenue decreased by -6.55%.
DNUT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.66% yearly.
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-171.43%
Revenue 1Y (TTM)-6.55%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-15.25%

3.2 Future

The Earnings Per Share is expected to grow by 3.75% on average over the next years.
Based on estimates for the next years, DNUT will show a decrease in Revenue. The Revenue will decrease by -1.26% on average per year.
EPS Next Y-169.82%
EPS Next 2Y-59.55%
EPS Next 3Y3.75%
EPS Next 5YN/A
Revenue Next Year-6.03%
Revenue Next 2Y-1.33%
Revenue Next 3Y-1.26%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DNUT Yearly Revenue VS EstimatesDNUT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DNUT Yearly EPS VS EstimatesDNUT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Forward Earnings ratio of 147.19, the valuation of DNUT can be described as expensive.
DNUT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. DNUT is more expensive than 70.15% of the companies in the same industry.
DNUT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.15.
Industry RankSector Rank
PE N/A
Fwd PE 147.19
DNUT Price Earnings VS Forward Price EarningsDNUT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

62.69% of the companies in the same industry are cheaper than DNUT, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.46
DNUT Per share dataDNUT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-59.55%
EPS Next 3Y3.75%

More info and screens

5

5. Dividend

5.1 Amount

DNUT has a Yearly Dividend Yield of 4.78%, which is a nice return.
In the last 3 months the price of DNUT has falen by -53.46%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
DNUT's Dividend Yield is rather good when compared to the industry average which is at 3.79. DNUT pays more dividend than 92.54% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.38, DNUT pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.78%

5.2 History

DNUT has been paying a dividend for over 5 years, so it has already some track record.
DNUT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
DNUT Yearly Dividends per shareDNUT Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

DNUT has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-136.93%
EPS Next 2Y-59.55%
EPS Next 3Y3.75%
DNUT Yearly Income VS Free CF VS DividendDNUT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

More info and screens

KRISPY KREME INC

NASDAQ:DNUT (5/30/2025, 8:00:01 PM)

After market: 2.91 +0.02 (+0.69%)

2.89

-0.04 (-1.37%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-06 2025-08-06/bmo
Inst Owners62.51%
Inst Owner Change-4.44%
Ins Owners3.86%
Ins Owner Change0.05%
Market Cap493.61M
Analysts76
Price Target10.15 (251.21%)
Short Float %29.63%
Short Ratio4.75
Dividend
Industry RankSector Rank
Dividend Yield 4.78%
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP-136.93%
Div Incr Years0
Div Non Decr Years3
Ex-Date04-23 2025-04-23 (0.035)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-45.6%
Min EPS beat(2)-89.88%
Max EPS beat(2)-1.32%
EPS beat(4)0
Avg EPS beat(4)-71.43%
Min EPS beat(4)-192.23%
Max EPS beat(4)-1.32%
EPS beat(8)2
Avg EPS beat(8)-43.93%
EPS beat(12)4
Avg EPS beat(12)-31.12%
EPS beat(16)5
Avg EPS beat(16)-23.81%
Revenue beat(2)0
Avg Revenue beat(2)-4.48%
Min Revenue beat(2)-4.66%
Max Revenue beat(2)-4.3%
Revenue beat(4)0
Avg Revenue beat(4)-3.06%
Min Revenue beat(4)-4.66%
Max Revenue beat(4)-1.21%
Revenue beat(8)1
Avg Revenue beat(8)-2.19%
Revenue beat(12)4
Avg Revenue beat(12)-1.43%
Revenue beat(16)5
Avg Revenue beat(16)-0.99%
PT rev (1m)-6.26%
PT rev (3m)-31.92%
EPS NQ rev (1m)-1076.33%
EPS NQ rev (3m)-164.75%
EPS NY rev (1m)-193.46%
EPS NY rev (3m)-127.32%
Revenue NQ rev (1m)-3.91%
Revenue NQ rev (3m)-12.51%
Revenue NY rev (1m)-3.37%
Revenue NY rev (3m)-10.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 147.19
P/S 0.31
P/FCF N/A
P/OCF 11.56
P/B 0.45
P/tB N/A
EV/EBITDA 16.46
EPS(TTM)0
EYN/A
EPS(NY)0.02
Fwd EY0.68%
FCF(TTM)-0.44
FCFYN/A
OCF(TTM)0.25
OCFY8.65%
SpS9.36
BVpS6.45
TBVpS-4.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.7%
ROE -1.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.78%
FCFM N/A
ROA(3y)-0.53%
ROA(5y)-0.89%
ROE(3y)-1.44%
ROE(5y)-3.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.61%
GM growth 5Y0.06%
F-Score4
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF N/A
Debt/EBITDA 10.51
Cap/Depr 87.84%
Cap/Sales 7.36%
Interest Coverage N/A
Cash Conversion 48%
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.28
Altman-Z 0.35
F-Score4
WACC8.23%
ROIC/WACCN/A
Cap/Depr(3y)96.05%
Cap/Depr(5y)105.48%
Cap/Sales(3y)7.25%
Cap/Sales(5y)7.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-171.43%
EPS Next Y-169.82%
EPS Next 2Y-59.55%
EPS Next 3Y3.75%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.55%
Revenue growth 3Y6.35%
Revenue growth 5Y11.66%
Sales Q2Q%-15.25%
Revenue Next Year-6.03%
Revenue Next 2Y-1.33%
Revenue Next 3Y-1.26%
Revenue Next 5YN/A
EBIT growth 1Y-518.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year538.31%
EBIT Next 3Y101.17%
EBIT Next 5YN/A
FCF growth 1Y-676.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-64.94%
OCF growth 3Y-31.28%
OCF growth 5Y-10.72%